Clesrovimab Antibody
Clesrovimab (MK1654) is a human monoclonal antibody targeting the RSV fusion (F) protein, developed for the prevention and treatment of respiratory syncytial virus infection. It is a research tool for studying RSV neutralization in vitro and evaluating prophylactic efficacy in animal models.
Product Specifications
Product Name Alternative
MK-1654, plants respiratory kinase
Target
RSV, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
4.64 mg/mL
Purity
96.50% (May vary between batches)
Molecular Weight
146.75 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog